Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT03098030 · COMPLETED
Trial details
- NCT number
- NCT03098030
- Sponsor
- United Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2020-01-27
- Enrollment
- 483
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.